ArticleNeurology and therapy2021

Editorial: A Time of Transition of Alzheimer's Disease in the Advent of Anti-Amyloid Monoclonal Antibodies.

Babak Tousi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.